Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Dubravka Škalamera
Combined Use of Subclinical Hydroxyurea and CHK1 Inhibitor Effectively Controls Melanoma and Lung Cancer Progression, With Reduced Normal Tissue Toxicity Compared to Gemcitabine
Molecular Oncology
Cancer Research
Medicine
Oncology
Genetics
Molecular Medicine
Related publications
Gemcitabine Combined With Capecitabine Compared to Gemcitabine With or Without Erlotinib as First-Line Chemotherapy in Patients With Advanced Pancreatic Cancer
Cancer Research and Treatment
Cancer Research
Oncology
Phase III Non-Inferiority Study Evaluating Efficacy and Safety of Low Dose Gemcitabine Compared to Standard Dose Gemcitabine With Platinum in Advanced Squamous Lung Cancer
EClinicalMedicine
Medicine
A Case of Late-Onset Gemcitabine Lung Toxicity
Clinical Medicine Insights: Oncology
Oncology
Metastatic Non-Small-Cell Lung Cancer and the Use of Gemcitabine During Pregnancy
Journal of Perinatology
Gynecology
Child Health
Pediatrics
Perinatology
Obstetrics
Vorinostat Combined With DNMTi Epigenetically Controls the Proliferation of Lung Cancer Cells A549
International Journal of Science and Research (IJSR)
Topotecan Synergizes With CHEK1 (CHK1) Inhibitor to Induce Apoptosis in Ovarian Cancer Cells
BMC Cancer
Cancer Research
Oncology
Genetics
Toxicity of Hydroxyurea in Rats and Dogs
Toxicologic Pathology
Forensic Medicine
Toxicology
Pathology
Cell Biology
Molecular Biology
Progression and Metastasis of Lung Cancer
Cancer and Metastasis Reviews
Cancer Research
Oncology
Patients With Peripheral Arterial Disease Exhibit Reduced Joint Powers Compared to Velocity-Matched Controls
Gait and Posture
Sports Science
Orthopedics
Sports Medicine
Rehabilitation
Biophysics
